BCO heads into its August 5 earnings report with short sellers adding positions, options traders seeking downside protection, and the stock sitting 26% above where it traded a month ago.
The most striking tension right now is between the price and the positioning. BCO closed at $122.00, up 26% over the past month after a strong Q2 beat in late June drove a 7.4% single-day jump. That kind of move tends to flush out the bears. Instead, short interest has climbed roughly 22% over the past month to 11.5% of free float — about 4.8 million shares — and added another 2.3% this week alone. Bears are rebuilding into strength, not retreating from it.
The lending market tells a more nuanced story, though. Availability is actually ample — at 381% of outstanding short interest, there are nearly four shares available to borrow for every one currently shorted. That's well into comfortable territory, down from above 600% in mid-June but nowhere near stressed. Cost to borrow has eased about 8% this week to just 0.43%, confirming there's no squeeze pressure in the pool. The short position is growing not because it's becoming expensive to hold, but because bears appear to have a view. Meanwhile, options positioning has shifted materially more defensive than usual. The put/call ratio jumped to 0.26 on Friday — nearly three standard deviations above its 20-day average of 0.16 — a reading that places it among the highest cautionary setups of the past year. That spike is notable precisely because the prior three weeks of PCR data were among the most call-heavy of the year, bottoming near 0.04 in late June. The options market has rotated sharply.
The Street remains constructive on paper, though the most recent analyst data worth citing is from early March, when Goldman Sachs raised its target to $145 and Truist Securities carried a $163 target — both with Buy ratings. The consensus mean target is $153, implying roughly 25% upside from current levels. The ORTEX short score of 66.7 ranks in the 5th percentile for short-score rank, meaning the short setup looks more elevated than almost all comparable names in the universe. The dividend score of 86 stands out, though the dividend history data is stale back to 2022 so should be treated with caution. The EV/EBITDA of about 6.4x and P/E near 8.9x look undemanding for a business with a five-year EBIT CAGR above 11%, but the valuation data carries a stale underlying date, so treat it as directional context rather than a precise read.
Brink's nearest correlated peers had a softer week. BV fell 3.2% and BDI dropped 5.3%, while BCO gained 1.6%. That relative outperformance is consistent with the post-earnings re-rating, but it also raises the stakes for August 5: the stock has already priced in good news.
Earnings history supports optimism about the release itself. The last three prints all produced positive next-day moves — the June 30 report alone drove 7.4% on the day and 12.7% over the five-day window. BCO has a track record of beating and running. What makes the current setup different is that shorts are not capitulating despite the rally, and options buyers just made a meaningful pivot toward puts in the final session before the earnings window. The print on August 5 therefore becomes less about whether BCO can beat estimates and more about whether the guide justifies the 26% re-rating the market has already delivered.
See the live data behind this article on ORTEX.
Open BCO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
